Hepatitis B virus surface antigen as a reporter of promoter activity by Marschall, M. et al.
Gene. 81 (1989) 109-117 
Elsevier 
GENE 03103 
Hepatitis B virus surface antigen as a reporter of promoter activity 
(Recombinant DNA; transient expression system; radioimmunoassay; 
immediate arly promoters) 
109 
Epstein-Barr virus regulation; 
Manfred Marschall, Manfred Motz, Ulrike Leser, Fritz Schwarzmann, Barbara Oker and Hans Wolf 
Max volt Pettenkofer-Institute, University of Munich, D-8000 Munich (F.R. G.) 
Received by W.C. Summers: 20 January 1989 
Accepted: 30 March 1989 
SUMMARY 
The coding sequence for the hepatitis B virus surface antigen (HBsAg) was used as a new reporter gene for 
studies on eukaryotic promoter activity and upstream regulatory sequences. The data observed in transfection 
assays were comparable to results obtained with conventional chloramphenicol acetyltransferase (CAT) assays, 
as was demonstrated using various transcriptional regulation sequences. The expression of HBsAg as a reporter 
protein offered some advantages: 
(i) In transient expression assays, a time course of promoter activity depending on variable culture conditions 
could be monitored over a period of time, since the HBsAg was secreted into the culture supematant. 
(ii) Evaluation of HBsAg from supematant aliquots and quantification of the corresponding promoter 
activities could be performed easily, using the very sensitive and readily available diagnostic HBsAg kits. 
(iii) In contrast o the conventional CAT assay, the cells remained available for further tests, e.g., Western 
blot, immunofluorescence or transcript analysis. 
Characteristics of several Epstein-Barr virus (EBV) promoters, depending on the virus state of EBV-positive 
B-cells (latency, chemical induction, lytic superinfection, truns-activation), were assayed using the HBsAg 
reporter system. 
Correspondence to:Prof. Dr. H. Wolf, Max von Pettenkofer-Insti- 
tute, Pettenkoferstr. 9a, 8000 Munich 2 (F.R.G.) 
Tel. (089)51605263; Fax (089)5380584. 
Abbreviations: Ap, ampicillin; bp, base pair(s); CAT, Cm acetyl- 
transferase; cat, gene encoding CAT; Cm, chloramphenicol; 
cpm, counts per minute; DEAE, diethylaminoethyl; dpt, days 
post-transfection; EBV, Epstein-Barr virus; HBsAg, HBV sur- 
face antigen; HBV, hepatitis B virus; kb, standard kilobase or 
1000 bp; lacP0, luc promoter-operator; LB, Luria-Bertani 
(medium); LMP, latent membrane protein; ORF, open reading 
frame; ori, origin of replication; PBS, phosphate-buffered saline 
(150 mM NaCl/lOO mM Na,HPO,.H,O pH 7.2); PolIk, 
Klenow (large) fragment of E. coli DNA polymerase I; RIA, 
radioimmunoassay; RPMI, Roswell Park Memorial Institute; R, 
resistance; SV40, simian virus 40; TPA, tumor promoting agent 
(phorbol-12-myristate-13-acetate);TTBS, 154 mM NaCl/lO mm 
Tris pH 7.5/0.5% Tween 20; UWGCG, Univ. of Wisconsin 
Genetics Computer Group. 
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INTRODUCTION 
Studies on activity and function of eukaryotic pro- 
moter sequences and upstream regulatory signals 
have been carried out using the DNA regions 
encoding CAT, B-galactosidase, alkaline phospha- 
tase or luciferase as reporter genes (An et al., 1982; 
Gorman et al., 1982; deWet et al., 1982; Yoon et al., 
1988), by correlating their expression with promoter 
activities. 
We established a new reporter system using 
HBsAg as the reporter protein, which is secreted into 
the culture supematant. The HBsAg is found in three 
variants of viral particles depending on the trans- 
lational start on the HBV genome. Two larger forms 
containing pre-S sequences are found in minor quan- 
tities, whereas the smallest HBsAg is the pre- 
dominant component. The HBsAg can be integrated 
into cellular membranes and secreted as 22-nm par- 
ticles into the culture supematant (Michel et al., 
1984). Using the HBsAg reporter system, kinetics of 
promoter activities could easily be analyzed under a 
variety of in vitro conditions. The diagnostic 
HBsAg-specific RIA provided a convenient assay 
with high sensitivity and low background. Since cell 
lysis was not required, in contrast to enzymatic tests, 
the transfected cells could be analyzed for gene ex- 
pression of the endogenous viral genome. 
The studies reported here focus on early events in 
the lytic cycle of EBV. In cell culture most of the 
EBV-transformed B lymphocytes carry the EBV ge- 
nome in a latent status. However, via distinct path- 
ways of stimulation including activation of viral im- 
mediate early promoters, these cells enter the lytic 
cycle leading to the synthesis of virus particles (in 
vitro forced by chemical inducers or by lytic superin- 
fection). This cycle consists of a strongly regulated 
follow-up of various groups of viral genes, starting 
with trans-acting immediate early proteins. Here we 
show the possibility of applying the HBsAg system 
for analyses of these regulatory aspects. 
MATERIALS AND METHODS 
(a) Sequences and promoter screening 
The B95-8 sequence of EBV (Baer et al., 1984) 
was analyzed by the UWGCG (Madison, WI) ‘find 
program for TATA-box consensus sequences (Cor- 
den et al., 1980). Convenient restriction sites located 
between the first methionine of the EBV ORFs 
BMLFl, BZLFI, BRLFI, BI’LF4, BALFZ and 
BNLFl (Farrell et al., 1987) and the cap sites of 
transcripts were used to insert the EBV promoters 
upstream from the reporter genes. The 5’-ends of the 
control regions were selected considering two 
aspects: first, the constructions should not contain 
any additional TATA boxes; secondly, consensus 
sequences for binding sites of cellular factors, e.g. 
AP-1 (Angel et al., 1987; Lee et al., 1987) located in 
upstream sequences should be included. 
(b) Construction and purification of plasmids 
The standard plasmids and EBV promoter con- 
structions were generated as shown in Figs. 1 and 2, 
and transformed in appropriate Escherichia coli 
strains. Transformants were grown in LB medium 
containing 50 pg Ap/ml. Plasmid preparations were 
carried out by the alkaline lysis procedure described 
by Maniatis et al. (1982). The purification from 
RNA and bacterial DNA was achieved by RNase A 
digestion (50 pg/ml) and high pressure liquid chro- 
matography (Pharmacia-LKB). DNA concentra- 
tions were calculated according to the absorbance at 
257 nm. 
(c) Cell culture, transfection, chemical induction and 
superinfection 
The EBV-positive non-producer Raji line was 
grown in RPM1 1640 medium supplemented with 
10% heat-inactivated foetal calf serum, 100 units/ml 
of penicillin and 250 pg/ml of streptomycin, at 37” C. 
Transfections were performed by a modification of 
the technique of McCutchan and Pagan0 (1968). 
Raji cells were split 15 h before transfection. 10’ cells 
were transfected with 6 pg of total DNA in 600 ~1 
transfection volume (pH 7.4) at a dextran concen- 
tration of 0.5 mg/ml. The cells were incubated for 
45 min at room temperature under gentle movement. 
Then the dextran was washed out with Tris-buffered 
saline and the cells were cultured in 5 ml of fresh 
medium. 
For the induction of the lytic cycle Raji cells were 
either induced chemically or superinfected with 
P3HR-1 virus (Bayliss and Wolf, 1981). Chemical 
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induction was achieved by addition of 40 mM TPA 
and 3 mM * Na-butyrate to the culture medium after 
transfection. For superinfection, virus pelleted from 
50 ml P3HR-1 culture supernatant was used per lo6 
Raji cells. The virus was prepared from the P3HR-1 
culture supematant (induced by TPA/butyrate for 10 
days) by centrifugation for 2 h at 20000 x g. The 
superinfection assay (lo6 cells per 0.5 ml) was 
incubated for 1 h at room temperature under gentle 
movement before the cells were transferred into fresh 
medium. 
Bsmli, sv40 
early promoter/enhancer 
/ 
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RESULTS AND DISCUSSION 
(a) Construction of reporter plasmids 
The sequences encoding HBsAg or CAT were 
used as reporter genes for various promoters (Figs. 1 
and 2). Both genes were brought under the control 
of the SV40 early promoter/enhancer for comparing 
the reporter systems. In all promoter constructions 
the transcription start point (cap site) was cloned in 
original position to its promoter, whereas the trans- 
Fig. 1. Reporter gene constructs. The coding sequence of HBsAg was derived from HBV subtype AYW DNA by the use ofXho1 (position 
131) and BglII sites (position 1986) (Galibert et al., 1979). The ends of this 1855bp fragment were converted to BglII (5’-end) and Sal1 
sites (3’-end), respectively, to generate pAvBI1, which was obtained from Albrecht von Brunn, ZMBH, Heidelberg. The BgZII-&/I 
fragment containing a 25-bp 5’-untranslated sequence followed by the ATG start codon of the HBsAg-encoding gene (lacking pre-S 
sequences) was subcloned using modified pUC vector polylinkers. The cat and SV40 promoter sequences (72-bp and 21-bp repeats are 
indicated by white dots) were subcloned from the original pSV2CAT construction (Gorman et al., 1982). TaqI and PstI sites were used 
to construct pSVCAT in pUCl8 vector (AccI-&I). For negative control (pCAT) the 2.2-kb Hind111 cut fragment was inserted into 
pUC18 vector in negative orientation. For the construction of pSVHBs the coding sequence of HBsAg was excised from pHBs 
(PstI-HindIII) and cloned downstream the SV40 promoter/enhancer in exchange for the cat gene in pSVCAT. All promoter test 
constructions were cloned in pUC vectors. The orientation of the reporter genes is shown by arrows. 
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lation start codon (first methionine of the ORF) was 
replaced by the start codon of the reporter gene. 
Constructions without viral promoter were used as 
negative control (reporter genes were cloned in nega- 
tive orientation with respect o the bacterial ZacPO) 
(Fig. 1). 
EBV promoters belonging to different functional 
classes were selected considering regulatory aspects 
(Fig. 2). Positive and negative transcriptional con- 
trol of immediate early genes (BZLFl, BMLFl, 
BRLFl, BI’LF4) (Chevallier-Greco et al., 1986; 
Lieberman et al., 1986; Seibl et al., 1986; B&in 
et al., 1987; Countryman et al., 1987; Seibl et al., 
1987; Hardwick et al., 1988; Leser et al., 1989; 
Marschall et al., 1989) was of main interest regarding 
possible virus/cell interactions. Promoter activity of 
the early gene BALF2 (~138) (Hatfull et al., 1988) 
and the latent membrane protein BNLFI (LMP) 
(Modrow and Wolf, 1986) was examined in com- 
parison to immediate arly gene regulation. 
(b) Hepatitis B virus surface antigen synthesis in 
transfected cells 
The EBV-positive non-producer B-cell line Raji 
was used for transfection assays. HBsAg production 
was shown l-5 dpt (pSVHBs) by indirect immuno- 
fluorescence, using a monoclonal antibody which 
recognized conformational epitopes of domain A of 
the surface antigen (Fig. 3,11.). Recombinant HBsAg 
particles were demonstrated as granulous cytoplas- 
mic structures. No background was seen in cells 
transfected with negative control plasmid pHBs (see 
Fig. 1). 
In parallel experiments, HBsAg production and 
secretion could be monitored by RIA (Fig. 3,1.). A 
kinetic study of supernatant samples from 1 until 
7 dpt (pSVHBs) (see Fig. 1) demonstrated the 
steady increase of high-level production of HBsAg in 
Raji cells, promoted by the SV40 early control 
region, leading to an accumulation of the reporter 
protein in the supematant. 
(c) Comparison of reporter systems 
HBsAg production after transfection with 
pSVHBs could be shown in Raji cells by RIA using 
cell extracts, as well as culture supematant (Fig. 4). 
Two days post-transfection the cell extracts con- 
tained optimal HBsAg concentrations, whereas four 
dpt the accumulation of secreted HBsAg resulted in 
even stronger RIA signals in samples of the supema- 
tant. 
Transfection with pSVHBs led to basal expres- 
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Fig. 2. Cloning of EBV promoter elements. The EBV standard genome is shown in its linearized form, subdivided into BamHI fragments. 
Regulatory ORFs are presented in an enlarged drawing (boldface arrows). The corresponding promoter elements (bent horizontal 
arrows) were cloned into cat and HBsAg constructions, as described in Fig. 1 (vertical arrows show polyadenylation signals; the EBV 
PstI repeats are indicated by repeated vertical lines). EBV DNA was derived from subclones of the B95-8 (Skare and Strominger, 1980) 
(BamHI S,BamHIZ,BamHI R,EamHI A)or M-ABAstrain (Polack et al., 1984)(H3-D1,922-20). The promoter elements were excised 
using restriction sites as indicated and subcloned into pUC-derived vectors. The original EBV DNA restriction sites were either directly 
used for insertion into pUC polylinker sites or filled-in by PolIk for blunt end ligation with HincII-digested pUC vector. Subsequently 
the EBV promoter sequences were inserted in pHBs (SstI-&I) or in pSVCAT where the SV40 sequence had been removed 
(SsrI-HindIII). 
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Fig. 3. HBsAg-specific RIA (I.) and immunofluorescence (II.). Raji cells were transfected with pHBs (LA, HA) and pSVHBs (LB, 1I.B). 
The SV40 early control element was stimulated by TPA induction. HBsAg production was assayed by the routine diagnostic RIA for 
HBsAg (Abbott). 0.5 ml of culture supematant was incubated with solid-phase-conjugated anti-HBsAg antibodies overnight at room 
temperature. After washing, the secondary antibody ( ‘251-labe11ed anti-HBsAg antibody, Abbott) was incubated at 42°C for 1 h. Specific 
binding of radioactively labelled antibodies was measured in a gamma-scintillator (cpm values x 103). For indirect immunofluorescence, 
transfected cells were cultured in Falcon Multiwell plates (six chambers, each containing 10’ cells in 5 ml medium). Samples were 
centrifuged at 1-5 dpt, washed in PBS and the cells were fixed on glass slides in ice-cold acetone for 5 min. After air drying, slides were 
stored at -20°C. Monoclonal antibodies against HBsAg (H35, Abbott) were diluted 1: 100 in PBS and incubated for 2 h at 37°C. After 
washing, the cells were incubated with a 1: 100 dilution of fluorescein isothiocyanate-linked goat anti-mouse antibody (Medac) for 1 h 
followed by a final rinse in PBS. Note the granulous, cytoplasmic localization of HBsAg in the transfected cells and the steady 
accumulation in the supematant with low background of the controls. 
sion due to the SV40 early promoter/enhancer, 
which could be stimulated by TPA induction. En- 
hancement of HBsAg production was also achieved 
by cotransfection with the EBV factor BMLFl, 
which was originally described as a promiscuous 
truns-activator (Lieberman et al., 1986). An expres- 
sion vector for BMLFl (including the short BSLFZ 
exon that is spliced to the 5’-end of BMLFI) was 
kindly provided by A. Sergeant, Lyon (pSVSM; 
Chevahier-Greco et al., 1986). 
These results were reproduced by parallel trans- 
fection assays with pSVCAT (analogous to 
pSVHBs). pCAT, containing no promoter se- 
quences, was used as a negative control. TPA induc- 
tion and trans-activation by the BMLFl protein led 
to highly elevated CAT activity in extracts from Raji 
cells transfected with pSVCAT, confuming the 
corresponding data of the HBsAg reporter system. 
No difference was noted between cell extracts pre- 
pared 2 or 4 dpt (data not shown). 
(d) Analysis of the Epstein-Barr virus promoters 
EBV promoters belonging to several regulatory 
classes were tested for their activity under a variety 
of conditions (Fig. 5). The control regions of BZLFI, 
BMLFl and BI’LF4 (immediate arly group) were 
shown to be switched on in Raji cells, in which 
latency was disrupted. The reporter gene construc- 
tion pSlHBs contains the promoter region of the 
spliced BSLFl IBMLSl gene in a minimal version of 
127 bp (Fig. 2). An AP-1 binding consensus se- 
5,0 cpm 
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Fig. 4. Comparison of SV40 promoter activities measured by HBsAg reporter system (I.) (see legend to Fig. 3) and CAT assay (II.). 
Raji cells were transfected with SV40 promoter standard constructs (see Fig. 1) (pSVHBs and pSVCAT; B and D) or negative control 
constructions lacking SV40 promoter sequences (pHBs and pCAT; A and C). The reporter production under different conditions was 
measured from cell extracts (A and B), as well as from culture supematant (C and D). Raji cells (1 and 4), Raji cells cotransfected with 
a BMLFZ expression vector (2 and 5) and Raji cells induced by TPA/butyrate (3 and 6) were used 2 dpt (1, 2, 3) and 4 dpt (4, 5, 6). 
The CAT assays were performed as described by Gorman et al. (1982). Two days posttransfection the cells were centrifuged, washed 
in PBS and lysed by sonication on ice (100 ~1 of 0.25 M Tris . HCl pH 8.0). Cell debris was removed by centrifugation for 5 min at 500 x g. 
The protein concentrations were equilibrated after measurement of the optical densities at 260 and 280 nm. 50 ~1 of the protein extract 
was mixed with a reaction mixture containing 1OOfll of 0.25 M Tris.HCl pH 8.0/20$ of 4mM acetyl coenzyme A (Pharmacia- 
LKB)/lO ~1 of 14C Cm (0.25 PCi, Amersham) and incubated for 1 h at 37°C. Cm and its acetylated products were extracted with 400 ~1 
of ethyl acetate and evaporated in a speed-vacuum centrifuge. Dried samples were suspended in 10 ~1 of ethyl acetate, spotted on silica 
gel thin-layer chromatography plates (Merck 5737) in chloroform/methanol (95 : 5) solvent. The plates were exposed against hyperfilm- 
/?max (Amersham) for 12 to 24 h. 
quence (Angel et al., 1987) is included, located 80 bp 
upstream from the TATA box (Corden et al., 1980). 
Furthermore, a CAAT motif (Efstratiadis et al., 
1980) was noticed 50 bp from the TATA box. In Raji 
cells pSlHBs was found to be inactive during laten- 
cy. Chemical induction by TPA/butyrate or superin- 
fection with the lytic EBV strain P3HR-1 (im- 
mediately following the dextran transfection) led to 
the activation of pSlHBs, resulting in a steady in- 
crease of HBsAg in the supernatant until 5 dpt. As 
Raji cells contain about 50 copies of a defective EB 
viral genome (Hatfull et al., 1988) chemical induc- 
tion led to the synthesis of the authentic EBV pro- 
teins. Therefore, as additional control, extracts of the 
transfected cells were tested on Western blots for the 
presence of EBV-specific proteins (Fig. 5B). Using 
BMLFI-specific serum, proteins were demonstrated 
in induced and superinfected Raji cells. Activation of 
the latent Raji EBV genome is correlated with the 
synthesis of a prominent 60-kDa protein encoded by 
BMLFllBSLF2, including additional modified poly- 
peptides, as described earlier (Marschall et al., 
1989). 
The promoters of BZLFI and BI’LF4 were acti- 
vated in latently infected Raji cells after TPA/buty- 
rate induction (Fig. 5C and D) via synthesis or acti- 
vation of viral and cellular truns-activators. Cotrans- 
fection with an expression vector for BMLFl protein 
up-regulated several reporter gene constructs, con- 
firming that BMLFl acts universally. Enhanced 
HBsAg production was measured in cotransfection 
assays with constructs containing the BZ’LF4 pro- 
moter (Fig. 5E), the promoter of BMLFI itself (data 
not shown) and the SV40 early promoter/enhancer 
(Fig. 4, rows 2 and 5). 
The promoter construction of BNLFl (pNHBs) 
showed activity when transfected in latent Raji cells 
(Fig. 5F). BNLFI transcription (first TATA box of 
the ORF), leading to the synthesis of the BNLFl 
membrane protein (LMP), is compatible with laten- 
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Fig. 5. EBV promoter activities in Raji cells. The kinetics of promoter activities were measured by the HBsAg reporter system (RIA, 
see legend to Fig. 3) from supernatant samples (A,C,D,E,F) and compared to specific proteins detected by Western blot (B) (days 
posttransfection indicated by numbers on bottoms). Raji cells were transfected with promoter constructions corresponding to the EBV 
genes BSLFZ/BMLFl (A), BI’LF4 (C,E), BZLFl (D) and ENLFZ (F) (see Fig. 2). The following conditions were created: transfection 
of latent Raji cells; transfection and subsequent induction by TPA/butyrate or superinfection with P3HR-1 virus; cotransfection with 
a BMLFl expression vector. As shown for BMLFI, promoter activity (A) and protein production (B) were examined in parallel. 
BMLFI-specific proteins (major product 60 kDa with modified species) were specified using a high-molecular-weight protein standard 
(Sigma) and are indicated by arrow heads. For Western blots, the cells were washed, lysed by sonication and the protein extracts were 
separated in 12.5% polyacrylamidegels (0.1% SDS) and electrophoretically transferred onto nitrocellulose (BA 85, Schleicher & Schtill). 
EBV ORF-specific rabbit antisera were incubated overnight at room temperature in a 1: 50 dilution. The blots were washed with TTBS 
and incubated for another 2 h at room temperature with peroxidase-conjugated antibodies against rabbit immunoglobulins (Dakopatts). 
After the final washing with TTBS, the blots were developed with 0.5 mg of 3,3’-diaminobenzidine per ml and 0.01% H,O, in 50 mM 
Tris (pH 7.6). 
cy. In contrast to BNLFl, no promoter activation of 
the BALFZ early gene (pAHBs) was detected in 
latent Raji cells (data not shown). 
(e) Conclusions 
For the evaluation of promoter activities we 
developed a new reporter system in which the repor- 
ter protein was detectable in the supernatant, taking 
advantage of the sensitive HBsAg RIA frequently 
used for diagnostic purposes. As our main interest 
was the regulation of EBV trans-acting genes, which 
are expressed in a strictly limited way and restricted 
in time, we needed to monitor the promoter activities 
over a certain time range under various growth con- 
ditions of different cell cultures (human B cell lines, 
human carcinoma cells, mouse fibroblasts). 
(i) Using the HBsAg reporter system we were 
able to study the activity of selected control regions 
over ten days by RIA and indirect immunofluore- 
scence. 
(ii) As the reporter protein was secreted to the 
supernatant, the cell extracts remained available for 
additional tests, e.g., Western blots. 
(iii) The results of the HBsAg reporter system 
were reproduced by experiments using the CAT 
assay system. 
(iv) The use of test constructions with different 
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viral promoters (SV40, EBV) showed that our new 
method could be employed universally. 
(v) Control transfections of reporter constructs 
without promoter sequences proved that 
background expression remained at a low level. 
EBV early and immediate early promoters were 
found to be down-regulated during latency and were 
activated by means of inducing the lytic expression 
in Raji cells, while the promoter of BNLFl (LMP) 
was shown to be active during the latent phase of 
infection. Using the HBsAg reporter system we 
could directly compare promoter activation and the 
start of protein synthesis of the corresponding gene 
encoded by the endogeneous EBV genome in Raji 
cells. The gene regulation of EBV was shown to 
occur on different levels, e.g., promoter activity 
(Chevallier-Greco et al., 1986) transcription ef- 
ficiency and RNA transport (Schwarzmann et al., 
1988; Leser et al., 1989), and translation and protein 
modification (Bayliss and Wolf, 1981; MarschalI 
et al., 1989). We developed a sensitive method to 
detect low-grade changes of gene activation on the 
promoter level. The HBsAg reporter system provides 
a general method for monitoring control elements in 
the kinetics of transient expression assays. 
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